Quick Dispatch:
Your dihexa hgf/c-met agonist Dihexa is a synthetic peptide derived from Angiotensin IV, engineered to cross the blood-brain barrier and activate the HGF/c-Met pathway — a primary driver of synaptogenesis and new neural connection growth. Researchers orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your dihexa hgf/c-met agonist Dihexa is a synthetic peptide derived from Angiotensin IV, engineered to cross the blood-brain barrier and activate the HGF/c-Met pathway — a primary driver of synaptogenesis and new neural connection growth. Researchers ships.
Need Help?
Questions about dihexa hgf/c-met agonist Dihexa is a synthetic peptide derived from Angiotensin IV, engineered to cross the blood-brain barrier and activate the HGF/c-Met pathway — a primary driver of synaptogenesis and new neural connection growth. Researchers, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for dihexa hgf/c-met agonist Dihexa is a synthetic peptide derived from Angiotensin IV, engineered to cross the blood-brain barrier and activate the HGF/c-Met pathway — a primary driver of synaptogenesis and new neural connection growth. Researchers in your area.
A novel agonist for the HGF receptor MET promotes differentiation of human pluripotent stem cells into hepatocyte‐like cells - Tauran - 2022 - Development, Growth & Differentiation
29.67
Exploring the science behind Dihexa., Preclinical research examines its interaction with the HGF/c-Met pathway and associated neuroplasticity markers in laboratory and animal models. Human data
22.85
dihexa hgf/c-met agonist Molecular mechanism(s) of regulation(s) of c-MET/ HGF signaling in head and neck cancer
26.94
Growth factors and their peptide mimetics for treatment of traumatic brain injury
27.33
Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted
24.22
Artificial human Met agonists based on macrocycle scaffolds
21.58
The illustration of the molecule mechanism of HGF/c-Met downstream
22.83
